Medwave — Investor Presentation (February 2005)
27 slides from Medwave's investor presentation, Feb 11, 2005

Slide 1: Medwave, Inc. Sensor Based Blood Pressure Solutions
Medwave, Inc. Sensor Based Blood Pressure Solutions

Slide 2: Safe Harbor Statement
Safe Harbor Statement As provided by the “Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995,” Medwave cautions that statements made in this presentation that are stated as expectations, plans, anticipations, prospects or future estimates or which otherwise look forward

Slide 3: Company Snapshot
Company Snapshot · Currently, Medwave develops, manufactures, and sells novel technologies for non-invasive blood-pressure monitoring · The Company began as a development company with the goal of creating a faster, safer, and more accurate alternative to non-invasive blood pressure monitoring · Unli

Slide 4: Medwave's Milestones
Medwave’s Milestones Medwave’s Milestones • Clinical studies published • New products launch • Vasotrax launch • Vasotrac early launch • 3Ci agreement • Tim O’Malley named CEO • Medwave’s IPO 19952000 • Enter prestigious medical centers • Clinical studies presented • Zoll OEM Agreement • Financing •

Slide 5: Medwave Meeting Milestones
Medwave Meeting Milestones · Tim O’Malley became CEO in Oct 1999 during Medwave’s development stage · Since that time... – The Company has raised $12.5 million. – 3 products have been developed and introduced into the market. – 11 clinical studies at prestigious medical centers have validated the Co

Slide 6: Business Model
Medwave’s Business Model · Replace blood pressure cuffs and other non-invasive monitoring devices with our superior sensor-based products in all environments: – Point of Care locations – physicians offices, point of incident, general care, skilled nursing facilities – Low end monitoring solutions –

Slide 7: Blood Pressure Monitoring Devices — Sought After Characteristics
Blood Pressure Monitoring Devices — Sought After Characteristics - · Non-invasive / safe · Accurate · Real-time · Patient-friendly · Can accommodate a variety of patient types and environments

Slide 8: Unique Product Offerings
Medwave’s Unique Product Offerings •Non-invasive system that provides continual blood pressure measurement with accuracy comparable to a radial artery catheter•Uses a patented method of measuring radial artery waveforms by capturing pulse pressure information during gradual direct compression of the

Slide 9: Alternative Methods
Alternative Methods •Direct / Invasive Methods •Direct placement of an arterial catheter (A-line) in an artery (radial, femoral, brachial) •Advantage: accurate; can measure pulsatile waveforms with each heartbeat; real -time • Disadvantages: • Patient discomfort • Cost: approx. $1,020 per patient pe

Slide 10: Advantage
Medwave’s Advantage · Medwave’s continual non-invasive blood pressure technology offers: – Similar speed and accuracy to invasive methods · 0.97 mean correlation coefficient · Slight changes in blood pressure are detected to a low of 40mmHg and a high of 240mmHg systolic, thus accommodating a broad

Slide 11: Clinical Advantage
Medwave’s Clinical Advantage

Slide 12: Automatic Cuff's Disadvantage
Automatic Cuff’s Disadvantage

Slide 13: Blood Pressure Monitoring Market Size
Blood Pressure Monitoring Market Size · Approximately 65MM Americans are considered hypertensive; this number has increased 30% in the past decade · One-third of the world’s adult population – over 1 billion – is expected to suffer from high blood pressure by 2025 · Target Market Breakdown: – Hospit

Slide 14: Blood Pressure Monitoring Market Dynamics
Blood Pressure Monitoring Market Dynamics · Historically, blood pressure monitoring has been accomplished by using either an invasive arterial catheter or a blood pressure cuff: –Blood Pressure Cuffs – introduced in late 1800’s –Invasive Arterial Catheters – introduced in mid 50’s –Automatic Blood P

Slide 15: Business Model — Hospital Market
Medwave’s Business Model — Hospital Market - Market Segment Primary Players Medwave Products Segment Addressed High End/ GEMS Philips, OEM Modules Systems integration Systems Draeger Bedside monitoring Mid Range GEMS Philips, OEM Module Vital signs Datascope, Welch Vasotrac Bedside monitoring Allyn,

Slide 16: Recent Accomplishments — Hospital Market
Medwave’s Recent Accomplishments — Hospital Market - · Completed 11 clinical studies validating technology across a wide spectrum of clinical environments and patient types · Introduced Disposable Sensor to create flexibility in purchase process · Built a direct sales force of 12 full-time salespeop

Slide 17: Focus — Hospital Market
Medwave’s Focus — Hospital Market - · Medwave’s initial commercialization attempts have been in areas where current methods of noninvasive monitoring have faced numerous challenges – Pediatrics • The size and shape of a child’s arm, as well as issues with movement and comfort, make traditional metho

Slide 18: Success — Hospital Market (Pediatrics)
Medwave’s Success — Hospital Market - • Pediatrics – Medwave’s Vasotrac 205A participated in clinical validation studies at Children’s Hospital of Boston (OR and Cardiac ICU) and Arkansas Children’s Hospital (Pediatric ICU) and received very high ratings at both – Customer testimonial : “ Due to the

Slide 19: Success — Hospital Market (Bariatrics)
Medwave’s Success — Hospital Market - • Bariatrics the blood pressure cuff does not fit the circumference and length of the patient’s arm, which can lead to false readings Inserting an A-line in a patient in this condition could take to 45-50 minutes and may cause serious complications medwave solut

Slide 20: Business Model — Alternative Care Market
Medwave’s Business Model — Alternative Care Market - Market Segment Primary Players Medwave Products Segment Addressed (release 2005) Defibrillation Zoll, Physio Universal Cardiac Control, Welch OEM Module Resuscitation Allyn, Cardiac Vasotrax Science Auto-X (release 2005)(release 2005) Transport Cr

Slide 21: Near-Term Goals — Alternative Care Market
Medwave’s Near-Term Goals - Alternative Care Market - · Enter market in 2005 –Introduce Auto-X in early 2005 directly into point of care market –Follow-up with Universal Platform in late 2005 · Hire 3 to 4 entry-level salespeople and enroll them in a 1-month intensive training program on on BP physi

Slide 22: Business Model — Consumer Market
Medwave’s Business Model — Consumer Market - Primary Players Medwave Products Segment Addressed Omron, Braun, Sanyo-Auto-XAt home monitoring Electronic, Welch Allyn, Nursing care Baumometer, Other Skilled nursing (mechanical) Mobile monitoring

Slide 23: Near-Term Goals — Consumer Market
Medwave’s Near-Term Goals — Consumer Market - · Clinical validation in hospital and alternative care markets will demonstrate that Medwave’s technology is superior to conventional blood pressure cuffs · Demonstrate that Medwave’s sensor technology is easier for at-home, unskilled users to administer

Slide 24: Mission
Medwave’s Mission · To continue to penetrate the professional markets, with leading edge products · To become the supplier of choice for point of care, and low end vital signs monitoring solutions · To become a valued partner to the Systems Suppliers, and become a part of their larger more comprehen

Slide 25: Anticipated Milestones
Medwave’s Anticipated Milestones · Increase revenue driven by OEM agreements and penetration of our direct sales force into automatic blood pressure and point of care markets with new products · At least 3 additional OEM agreements signed up by the end of 2005 · Gain several new high-end customers a

Slide 26: Anticipated Use of Proceeds
Anticipated Use of Proceeds · Hire Executive Business Development employee to focus on business partnerships · Hire Chief Financial Officer · Hire additional engineering resources to implement OEM agreements and obtain additional agreements · Hire additional Hospital and Alternative Care sales profe

Slide 27: Investment Highlights
Investment Highlights · Medwave is positioned for tremendous growth in the short term · Large and growing market — $2.1 billion – that needs the technology advancement and change that Medwave provides – Recent studies conclude that more than one billion people worldwide will suffer from blood pressu
Source: SEC EDGAR · 8-K filed Feb 11, 2005